GRP and small cell lung carcinoma: Diagnostic properties of proGRP in SCLC are well-described but most of the diagnostic performance studies do not include pneumonia and COPD in the control group although some studies link higher proGRP to pneumonia, pneumonitis, COPD, tuberculosis and pulmonary fibrosis (6, 11, 20).